Inclisiran and other revenues sources | ALNY Message Board Posts

Alnylam Pharmaceuticals

  ALNY website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email

ALNY   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34756 of 34847  at  1/17/2020 9:47:50 PM  by


 In response to msg 34753 by  Steve_382
view thread

Re: Inclisiran and other revenues sources

Less than two months ago, Novartis paid nearly $10 billion to acquire The Medicines Company, a deal driven by one asset, an RNAi heart drug called inclisiran. On the first day of JPM, the Swiss pharma announced ambitious plans alongside U.K. health officials to study inclisiran in a wide patient population and to ramp up manufacturing capacity for RNAi medicines.

"I believe inclisiran has the potential to be one of the largest, if not the largest, medicine at Novartis in our history," Novartis CEO Vas Narasimhan said Monday.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 138
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by